Stay updated on Bispecific Antibody MCLA-158 Clinical Trial

Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page version updated from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' navigation element was removed.
    Difference
    0.1%
    Check dated 2025-09-15T01:08:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.1%
    Check dated 2025-09-07T21:38:05.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific drug information for Pembrolizumab and detailed resources related to various gastrointestinal diseases, while also removing some location-related terms and previous drug classifications.
    Difference
    3%
    Check dated 2025-08-31T19:52:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.1%
    Check dated 2025-08-24T15:52:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-17T12:29:04.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-10T08:40:12.000Z thumbnail image

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.